Literature DB >> 21415245

Anaerobic bacteria in cystic fibrosis: pathogens or harmless commensals?

Andrew M Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21415245     DOI： 10.1136/thx.2010.157875

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  10 in total

1.  Contribution of Veillonella parvula to Pseudomonas aeruginosa-mediated pathogenicity in a murine tumor model system.

Authors:  Christian Pustelny; Uliana Komor; Vinay Pawar; Anne Lorenz; Agata Bielecka; Annette Moter; Benjamin Gocht; Denitsa Eckweiler; Mathias Müsken; Claudia Grothe; Heinrich Lünsdorf; Siegfried Weiss; Susanne Häussler
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

Review 2.  Potential Contributions of Anaerobes in Cystic Fibrosis Airways.

Authors:  Christina S Thornton; Michael G Surette
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

3.  High individuality of respiratory bacterial communities in a large cohort of adult cystic fibrosis patients under continuous antibiotic treatment.

Authors:  Rolf Kramer; Annette Sauer-Heilborn; Tobias Welte; Ruy Jauregui; Ingrid Brettar; Carlos A Guzman; Manfred G Höfle
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

Review 4.  The Microbiome in Cystic Fibrosis.

Authors:  Yvonne J Huang; John J LiPuma
Journal:  Clin Chest Med       Date:  2015-12-23       Impact factor: 2.878

Review 5.  Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.

Authors:  Christiaan Dm Wijers; James F Chmiel; Benjamin M Gaston
Journal:  Chron Respir Dis       Date:  2017-03-06       Impact factor: 2.444

Review 6.  The Consequences of Being in an Infectious Biofilm: Microenvironmental Conditions Governing Antibiotic Tolerance.

Authors:  Majken Sønderholm; Thomas Bjarnsholt; Maria Alhede; Mette Kolpen; Peter Ø Jensen; Michael Kühl; Kasper N Kragh
Journal:  Int J Mol Sci       Date:  2017-12-12       Impact factor: 5.923

Review 7.  Factoring in the Complexity of the Cystic Fibrosis Lung to Understand Aspergillus fumigatus and Pseudomonas aeruginosa Interactions.

Authors:  Emily Beswick; Jorge Amich; Sara Gago
Journal:  Pathogens       Date:  2020-08-06

8.  Microbiome networks and change-point analysis reveal key community changes associated with cystic fibrosis pulmonary exacerbations.

Authors:  Mehdi Layeghifard; Hannah Li; Pauline W Wang; Sylva L Donaldson; Bryan Coburn; Shawn T Clark; Julio Diaz Caballero; Yu Zhang; D Elizabeth Tullis; Yvonne C W Yau; Valerie Waters; David M Hwang; David S Guttman
Journal:  NPJ Biofilms Microbiomes       Date:  2019-01-21       Impact factor: 7.290

9.  An observational study of anaerobic bacteria in cystic fibrosis lung using culture dependant and independent approaches.

Authors:  Claudie Lamoureux; Charles-Antoine Guilloux; Clémence Beauruelle; Stéphanie Gouriou; Sophie Ramel; Anne Dirou; Jean Le Bihan; Krista Revert; Thomas Ropars; Rosyne Lagrafeuille; Sophie Vallet; Rozenn Le Berre; Emmanuel Nowak; Geneviève Héry-Arnaud
Journal:  Sci Rep       Date:  2021-03-25       Impact factor: 4.379

10.  Porphyromonas pasteri and Prevotella nanceiensis in the sputum microbiota are associated with increased decline in lung function in individuals with cystic fibrosis.

Authors:  Karmel Webb; Nur Masirah M Zain; Iain Stewart; Andrew Fogarty; Edward F Nash; Joanna L Whitehouse; Alan R Smyth; Andrew K Lilley; Alan Knox; Paul Williams; Miguel Cámara; Kenneth Bruce; Helen L Barr
Journal:  J Med Microbiol       Date:  2022-02       Impact factor: 2.472
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.